Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy

被引:36
作者
Hachem, R
Graviss, L
Hanna, H
Arbuckle, R
Dvorak, T
Hackett, B
Gonzalez, V
Perego, C
Tarrand, J
Raad, I
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis, Unit 402, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pharm, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA
关键词
D O I
10.1086/502411
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
OBJECTIVE: To determine the impact of stool surveillance cultures of critically ill patients on controlling vancomycin-resistant enterococci (VRE) outbreak bacteremia. DESIGN: Stool surveillance cultures were performed on patients who had hematologic malignancy or were critically ill at the time of hospital admission to identify those colonized with VRE. Hence, contact isolation was initiated. SETTING: A tertiary-care cancer center with a high prevalence of VRE. PARTICIPANTS: All patients with hematologic malignancy who were admitted to the hospital as well as all of those admitted to the intensive care unit were eligible. RESULTS: Active stool surveillance cultures performed between 1997 and 2001 decreased the incidence density of VRE bacteremias eightfold while vancomycin use remained constant. In fiscal year (FY) 1997 and FY 1998, there were five and three VRE outbreak bacteremias, respectively. The outbreak clones were responsible for infection in 69% of those patients with VRE bacteremia. However, the stool surveillance program resulted in the complete control of VRE bacteremia by FY 1999 until the end of the study. CONCLUSION: Despite the steady use of vancomycin, the active surveillance program among high-risk patients with hematologic malignancy and those who were critically ill resulted in the complete control of VRE outbreak bacteremia at our institution.
引用
收藏
页码:391 / 394
页数:4
相关论文
共 15 条
[1]
Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality [J].
Edmond, MB ;
Ober, JF ;
Dawson, JD ;
Weinbaum, DL ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1234-1239
[2]
Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2 [J].
Fridkin, SK ;
Steward, CD ;
Edwards, JR ;
Pryor, ER ;
McGowan, JE ;
Archibald, LK ;
Gaynes, RP ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :245-252
[3]
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units [J].
Fridkin, SK ;
Edwards, JR ;
Courval, JM ;
Hill, H ;
Tenover, FC ;
Lawton, R ;
Gaynes, RP ;
McGowan, JE .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (03) :175-183
[4]
Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria [J].
Grayson, ML ;
Grabsch, EA ;
Johnson, PDR ;
Olden, D ;
Aberline, M ;
Li, HY ;
Hogg, G ;
Abbott, M ;
Kerr, PG .
MEDICAL JOURNAL OF AUSTRALIA, 1999, 171 (03) :133-136
[5]
Management of an outbreak of vancomycin-resistant enterococci in the medical intensive care unit of a cancer center [J].
Hanna, H ;
Umphrey, J ;
Tarrand, J ;
Mendoza, M ;
Raad, I .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (04) :217-219
[6]
Surveillance strategies and impact of vancomycin-resistant enterococcal colonization and infection in critically ill patients [J].
Hendrix, CW ;
Hammond, JMJ ;
Swoboda, SM ;
Merz, WG ;
Harrington, SM ;
Perl, TM ;
Dick, JD ;
Borschel, DM ;
Halczenko, PW ;
Pelz, RK ;
Rocco, LE ;
Conway, JE ;
Brower, RG ;
Lipsett, PA .
ANNALS OF SURGERY, 2001, 233 (02) :259-265
[7]
Jarvis WR, 1998, AM J INFECT CONTROL, V26, P522
[8]
Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality [J].
Lautenbach, E ;
Bilker, WB ;
Brennan, PJ .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (05) :318-323
[9]
Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting [J].
Montecalvo, MA ;
Jarvis, WR ;
Uman, J ;
Shay, DK ;
Petrullo, C ;
Rodney, K ;
Gedris, C ;
Horowitz, HW ;
Wormser, GP .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (04) :269-272
[10]
Bloodstream infections with vancomycin-resistant enterococci [J].
Montecalvo, MA ;
Shay, DK ;
Patel, P ;
Tacsa, L ;
Maloney, SA ;
Jarvis, WR ;
Wormser, GP .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (13) :1458-1462